<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35415778</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7479</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</Title><ISOAbbreviation>Neurotherapeutics</ISOAbbreviation></Journal><ArticleTitle>Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>1085</StartPage><EndPage>1101</EndPage><MedlinePgn>1085-1101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13311-022-01233-8</ELocationID><Abstract><AbstractText>The study of the role of retroviruses in amyotrophic lateral sclerosis (ALS) dates back to the 1960s shortly after transposable elements themselves were first discovered. It was quickly realized that in wild mice both horizontal and vertical transmissions of retroviral elements were key to the development of an ALS-like syndrome leading to the postulate that endogenous retroviruses (ERVs) contribute significantly to the pathogenicity of this disease. Subsequent studies identified retroviral reverse transcriptase activity in brains of individuals with ALS from Guam. However, except for a single study from the former Soviet Union, ALS could not be transmitted to rhesus macaques. The discovery of an ALS-like syndrome in human immunodeficiency virus (HIV) and human T cell leukemia virus infected individuals led to renewed interest in the field and reverse transcriptase activity was found in the blood and cerebrospinal fluid of individuals with sporadic ALS. However, exogenous retroviruses could not be found in individuals with ALS which further reinforced the possibility of involvement of a human ERV (HERV). The first demonstration of the involvement of a HERV was the discovery of the activation of human endogenous retrovirus-K subtype HML-2 in the brains of individuals with ALS. The envelope protein of HML-2 is neurotoxic and transgenic animals expressing the envelope protein develop an ALS-like syndrome. Activation of HML-2 occurs in the context of generalized transposable element activation and is not specific for ALS. Individuals with HIV-associated ALS show a remarkable response to antiretroviral therapy; however, antiretroviral trials in ALS down-regulate HML-2 without ameliorating the disease. This highlights the need for specific drugs to be developed against HML-2 as a novel therapeutic target for ALS. Other approaches might include antisense oligonucleotides, shRNA targeted against the envelope gene or antibodies that can target the extracellular envelope protein. Future clinical trials in ALS should consider combination therapies to control these ERVs.</AbstractText><CopyrightInformation>&#xa9; 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenxue</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandya</LastName><ForeName>Darshan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasternack</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Montojo</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozak</LastName><ForeName>Christine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Avindra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0927-5855</Identifier><AffiliationInfo><Affiliation>Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA. natha@ninds.nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotherapeutics</MedlineTA><NlmUniqueID>101290381</NlmUniqueID><ISSNLinking>1878-7479</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004251">DNA Transposable Elements</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016376">Oligonucleotides, Antisense</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.49</RegistryNumber><NameOfSubstance UI="D012194">RNA-Directed DNA Polymerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004251" MajorTopicYN="N">DNA Transposable Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020077" MajorTopicYN="Y">Endogenous Retroviruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016376" MajorTopicYN="N">Oligonucleotides, Antisense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012194" MajorTopicYN="N">RNA-Directed DNA Polymerase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiretroviral drugs</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Human endogenous retrovirus</Keyword><Keyword MajorTopicYN="N">Human immunodeficiency virus</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Murine leukemia virus</Keyword><Keyword MajorTopicYN="N">Retrotransposons</Keyword><Keyword MajorTopicYN="N">Transposable elements</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35415778</ArticleId><ArticleId IdType="pmc">PMC9587200</ArticleId><ArticleId IdType="doi">10.1007/s13311-022-01233-8</ArticleId><ArticleId IdType="pii">10.1007/s13311-022-01233-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>McClintock B. The origin and behavior of mutable loci in maize. Proc Natl Acad Sci. 1950;36:344&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1063197</ArticleId><ArticleId IdType="pubmed">15430309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, Fitzhugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, Levine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237011</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace JK, Feschotte C. The evolutionary history of human DNA transposons: Evidence for intense activity in the primate lineage. Genome Res. 2007;17:422&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1832089</ArticleId><ArticleId IdType="pubmed">17339369</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeke JD, Garfinkel DJ, Styles CA, Fink GR. Ty elements transpose through an RNA intermediate. Cell. 1985;40:491&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">2982495</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JS. Non-long terminal repeat (non-LTR) retrotransposons: mechanisms, recent developments, and unanswered questions. Mob DNA. 2010;1:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2881922</ArticleId><ArticleId IdType="pubmed">20462415</ArticleId></ArticleIdList></Reference><Reference><Citation>Deininger P. Alu elements: know the SINEs. Genome Biol. 2011;12:236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3334610</ArticleId><ArticleId IdType="pubmed">22204421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hancks DC, Kazazian HH. Active human retrotransposons: variation and disease. Curr Opin Genet Dev. 2012;22:191&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3376660</ArticleId><ArticleId IdType="pubmed">22406018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills RE, Bennett EA, Iskow RC, Devine SE. Which transposable elements are active in the human genome? Trends in genetics : TIG. 2007;23:183&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17331616</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoye JP. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol. 2012;10:395&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">22565131</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotman G, Itin A, Keshet E. 'Solo' large terminal repeats (LTR) of an endogenous retrovirus-like gene family (VL30) in the mouse genome. Nucleic Acids Res. 1984;12:2273&#x2013;2282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC318661</ArticleId><ArticleId IdType="pubmed">6324110</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos KM, Brown JKM, Bennetzen JL. Genome size reduction through illegitimate recombination counteracts genome expansion in Arabidopsis. Genome Res. 2002;12:1075&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC186626</ArticleId><ArticleId IdType="pubmed">12097344</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoye JP. Endogenous retroviruses: Still active after all these years? Curr Biol. 2001;11:914&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719237</ArticleId></ArticleIdList></Reference><Reference><Citation>Jern P, Coffin JM. Effects of retroviruses on host genome function. Annu Rev Genet. 2008;42:709&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">18694346</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B, Sechi LA, Kelvin DJ. Human Endogenous Retrovirus K (HML-2) in Health and Disease. Front Microbiol. 2020;11:1690&#x2013;1690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7380069</ArticleId><ArticleId IdType="pubmed">32765477</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoye JP, Moroni C, Coffin JM. Virological events leading to spontaneous AKR thymomas. J Virol. 1991;65:1273&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC239902</ArticleId><ArticleId IdType="pubmed">1847454</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian RP, Wildschutte JH, Russo C, Coffin JM. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology. 2011;8:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228705</ArticleId><ArticleId IdType="pubmed">22067224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildschutte JH, Williams ZH, Montesion M, Subramanian RP, Kidd JM, Coffin JM. Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc Natl Acad Sci U S A. 2016;113:E2326&#x2013;E2334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843416</ArticleId><ArticleId IdType="pubmed">27001843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruprecht K, Ferreira H, Flockerzi A, Wahl S, Sauter M, Mayer J, Mueller-Lantzsch N. Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21. J Virol. 2008;82:10008&#x2013;10016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566279</ArticleId><ArticleId IdType="pubmed">18684837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Medynets M, Johnson KR, Doucet-O'Hare TT, DiSanza B, Li W, Xu Y, Bagnell A, Tyagi R, Sampson K, Malik N, Steiner J, Hadegan A, Kowalak J, O'Malley J, Maric D, Nath A. Regulation of stem cell function and neuronal differentiation by HERV-K via mTOR pathway. Proc Natl Acad Sci USA. 2020;117:17842&#x2013;17853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395438</ArticleId><ArticleId IdType="pubmed">32669437</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucet-O'Hare TT, DiSanza BL, DeMarino C, Atkinson AL, Rosenblum JS, Henderson LJ, Johnson KR, Kowalak J, Garcia-Montojo M, Allen SJ, Orr BA, Santi M, Wang T, Fathi S, Lee MH, Sampson K, Li W, Zhuang Z, Nath A. SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression. Sci Rep. 2021;11:12893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8213802</ArticleId><ArticleId IdType="pubmed">34145313</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A.&#xa0;Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015;7:307ra153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol. 2011;69:141&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3052883</ArticleId><ArticleId IdType="pubmed">21280084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J, Harz C, Sanchez L, Pereira GC, Maldener E, Heras SR, Ostrow LW, Ravits J, Batra R, Meese E, Garcia-Perez JL, Goodier JL. Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins. Mol Neurodegener. 2018;13:39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091006</ArticleId><ArticleId IdType="pubmed">30068350</ArticleId></ArticleIdList></Reference><Reference><Citation>Garson JA, Usher L, Al-Chalabi A, Huggett J, Day EF, McCormick AL. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2019;7:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421708</ArticleId><ArticleId IdType="pubmed">30885274</ArticleId></ArticleIdList></Reference><Reference><Citation>Payer LM, Burns KH. Transposable elements in human genetic disease. Nat Rev Genet. 2019;20:760&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">31515540</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Babarinde IA, Sun L, Xu S, Chen R, Shi J, Wei Y, Li Y, Ma G, Zhuang Q, Hutchins AP, Chen J. Identifying transposable element expression dynamics and heterogeneity during development at the single-cell level with a processing pipeline scTE. Nat Commun. 2021;12:1456&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7935913</ArticleId><ArticleId IdType="pubmed">33674594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Tam OH, Paniagua E, Hammell M. TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets. Bioinformatics (Oxford, England) 2015;31:3593&#x2013;3599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4757950</ArticleId><ArticleId IdType="pubmed">26206304</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Lin L, Malhotra R, Yang L, Acharya R, Poss M. A computational framework to assess genome-wide distribution of polymorphic human endogenous retrovirus-K In human populations. PLoS Comput Biol. 2019;15:e1006564&#x2013;e1006564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456218</ArticleId><ArticleId IdType="pubmed">30921327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, Propp N, Consortium NA, Fagegaltier D, Harris BT, Ostrow LW, Phatnani H, Ravits J, Dubnau J, Gale Hammell M. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164&#x2013;1177 e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilber LA, Bajdakova ZL, Gardasjan AN, Konovalov NV, Bunina TL, Barabadze EM. Study of the Etiology of Amyotrophic Lateral Sclerosis. Bull World Health Organ. 1963;29:449&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2555002</ArticleId><ArticleId IdType="pubmed">14099672</ArticleId></ArticleIdList></Reference><Reference><Citation>Brody JA, Hadlow WJ, Hotchin J, Johnson RT, Koprowski H, Kurland LT. Soviet Search for Viruses That Cause Chronic Neurologic Diseases in the U.S.S.R. Science. 1965;147:1114&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">14242031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs CJ, Jr, Gajdusek DC. Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-Parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology. J Clin Pathol Suppl (R Coll Pathol) 1972;6:132&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1347262</ArticleId><ArticleId IdType="pubmed">4218241</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs CJ, Jr, Gajdusek DC. An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia, and Parkinson's disease. Adv Neurol. 1982;36:343&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">6817614</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowder LA, Schonberger LB, Dodd RY, Steele WR. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk. Transfusion. 2017;57:1875&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6553617</ArticleId><ArticleId IdType="pubmed">28444687</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K, Puoti G, Cohen ML, Schonberger LB, Cali I. Human prion diseases: surgical lessons learned from iatrogenic prion transmission. Neurosurg Focus. 2016;41:E10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5082740</ArticleId><ArticleId IdType="pubmed">27364252</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddox RA, Belay ED, Curns AT, Zou WQ, Nowicki S, Lembach RG, Geschwind MD, Haman A, Shinozaki N, Nakamura Y, Borer MJ, Schonberger LB. Creutzfeldt-Jakob disease in recipients of corneal transplants. Cornea. 2008;27:851&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644288</ArticleId><ArticleId IdType="pubmed">18650677</ArticleId></ArticleIdList></Reference><Reference><Citation>Douet JY, Huor A, Cassard H, Lugan S, Aron N, Mesic C, Vilette D, Barrio T, Streichenberger N, Perret-Liaudet A, Delisle MB, Peran P, Deslys JP, Comoy E, Vilotte JL, Goudarzi K, Beringue V, Barria MA, Ritchie DL, Ironside JW, Andreoletti O. Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients. Acta Neuropathol Commun. 2021;9:145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403347</ArticleId><ArticleId IdType="pubmed">34454616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Mead S, Ellis M, Wadsworth JD, Nicoll AJ, Kenny J, Launchbury F, Linehan J, Richard-Loendt A, Walker AS, Rudge P, Collinge J, Brandner S. Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature. 2015;525:247&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">26354483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie DL, Adlard P, Peden AH, Lowrie S, Le Grice M, Burns K, Jackson RJ, Yull H, Keogh MJ, Wei W, Chinnery PF, Head MW, Ironside JW. Amyloid-beta accumulation in the CNS in human growth hormone recipients in the UK. Acta Neuropathol. 2017;134:221&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508038</ArticleId><ArticleId IdType="pubmed">28349199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali I, Cohen ML, Haik S, Parchi P, Giaccone G, Collins SJ, Kofskey D, Wang H, McLean CA, Brandel JP, Privat N, Sazdovitch V, Duyckaerts C, Kitamoto T, Belay ED, Maddox RA, Tagliavini F, Pocchiari M, Leschek E, Appleby BS, Safar JG, Schonberger LB, Gambetti P. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-beta pathology: an international study. Acta Neuropathol Commun. 2018;6:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5759292</ArticleId><ArticleId IdType="pubmed">29310723</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ. Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol. 2013;70:462&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3678373</ArticleId><ArticleId IdType="pubmed">23380910</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappaport EB, Graham DJ. Pituitary growth hormone from human cadavers: neurologic disease in ten recipients. Neurology. 1987;37:1211&#x2013;1213.</Citation><ArticleIdList><ArticleId IdType="pubmed">3474545</ArticleId></ArticleIdList></Reference><Reference><Citation>Stansly PG. Non-oncogenic infectious agents associated with experimental tumors. Prog Exp Tumor Res. 1965;7:224&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">5329667</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner MB. Retroviruses and wild mice: an historical and personal perspective. Adv Cancer Res. 1994;65:169&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">7879665</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette Y, Hanna Z, Savard P, Brousseau R, Robitaille Y, Jolicoeur P. Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene. Proc Natl Acad Sci U S A. 1989;86:3896&#x2013;3900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC287248</ArticleId><ArticleId IdType="pubmed">2542954</ArticleId></ArticleIdList></Reference><Reference><Citation>DesGroseillers L, Rassart E, Robitaille Y, Jolicoeur P. Retrovirus-induced spongiform encephalopathy: the 3'-end long terminal repeat-containing viral sequences influence the incidence of the disease and the specificity of the neurological syndrome. Proc Natl Acad Sci U S A. 1985;82:8818&#x2013;8822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC391529</ArticleId><ArticleId IdType="pubmed">3866255</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona SM, Dunphy JM, Das AS, Lynch CR, Lynch WP. Astrocyte Infection Is Required for Retrovirus-Induced Spongiform Neurodegeneration Despite Suppressed Viral Protein Expression. Front Neurosci. 2019;13:1166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6828646</ArticleId><ArticleId IdType="pubmed">31736699</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Davey RA, Sivaramakrishnan S, Lynch WP. Postinhibitory rebound neurons and networks are disrupted in retrovirus-induced spongiform neurodegeneration. J Neurophysiol. 2014;112:683&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4122699</ArticleId><ArticleId IdType="pubmed">25252336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis. 2002;186(Suppl 2):S193&#x2013;S198.</Citation><ArticleIdList><ArticleId IdType="pubmed">12424697</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola MV, Frazier M, White L, Brody J, Spiegelman S. RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from Guamanian patients. J Exp Med. 1975;142:483&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2189894</ArticleId><ArticleId IdType="pubmed">49390</ArticleId></ArticleIdList></Reference><Reference><Citation>Garruto RM, Gajdusek C, Chen KM. Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Ann Neurol. 1980;8:612&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">7212649</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick AL, Brown RH, Jr, Cudkowicz ME, Al-Chalabi A, Garson JA. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 2008;70:278&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">18209202</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, Garson JA. Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. J Med Virol. 2000;61:527&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">10897073</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGowan DJ, Scelsa SN, Imperato TE, Liu KN, Baron P, Polsky B. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology. 2007;68:1944&#x2013;1946.</Citation><ArticleIdList><ArticleId IdType="pubmed">17536052</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele AJ, Al-Chalabi A, Ferrante K, Cudkowicz ME, Brown RH, Jr, Garson JA. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 2005;64:454&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YJ, Fan Y, Laurie P, Kim JM, Ravits J. No evidence of HIV pol gene in spinal cord tissues in sporadic ALS by real-time RT-PCR. Amyotroph Lateral Scler. 2010;11:91&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">19322704</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan KH, Y., Fu, Y., , et al. Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia. Communications Medicine. 2021;1:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8788987</ArticleId><ArticleId IdType="pubmed">35083468</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chen Y, Zhang N, Fan D. Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2021 doi: 10.1080/21678421.2021.1936061:1-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1936061:1-8</ArticleId><ArticleId IdType="pubmed">34151656</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner J,; Bachani, M., Malik, N., , et al. Neurotoxic Properties of Human Endogenous Retrovirus-K Envelope Protein and Detection in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis. Ann Neurol. 2021;90:S213.</Citation></Reference><Reference><Citation>Curzio DD, Gurm M, Turnbull M, Nadeau MJ, Meek B, Rempel JD, Fineblit S, Jonasson M, Hebert S, Ferguson-Parry J, Douville RN.&#xa0;Pro-Inflammatory Signaling Upregulates a Neurotoxic Conotoxin-Like Protein Encrypted Within Human Endogenous Retrovirus-K. Cells. 2020;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407490</ArticleId><ArticleId IdType="pubmed">32629888</ArticleId></ArticleIdList></Reference><Reference><Citation>Arru G, Mameli G, Deiana GA, Rassu AL, Piredda R, Sechi E, Caggiu E, Bo M, Nako E, Urso D, Mariotto S, Ferrari S, Zanusso G, Monaco S, Sechi G, Sechi LA. Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases. Eur J Neurol. 2018;25:1076&#x2013;e84.</Citation><ArticleIdList><ArticleId IdType="pubmed">29603839</ArticleId></ArticleIdList></Reference><Reference><Citation>Simula ER, Arru G, Zarbo IR, Solla P, Sechi LA. TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients. Viruses. 2021;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8623164</ArticleId><ArticleId IdType="pubmed">34835107</ArticleId></ArticleIdList></Reference><Reference><Citation>Arru G, Galleri G, Deiana GA, Zarbo IR, Sechi E, Bo M, Cadoni MPL, Corda DG, Frau C, Simula ER, Manca MA, Galistu F, Solla P, Manetti R, Sechi GP, Sechi LA. 2021. HERV-K Modulates the Immune Response in ALS Patients. Microorganisms 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8399181</ArticleId><ArticleId IdType="pubmed">34442863</ArticleId></ArticleIdList></Reference><Reference><Citation>Dembny P, Newman AG, Singh M, Hinz M, Szczepek M, Kruger C, Adalbert R, Dzaye O, Trimbuch T, Wallach T, Kleinau G, Derkow K, Richard BC, Schipke C, Scheidereit C, Stachelscheid H, Golenbock D, Peters O, Coleman M, Heppner FL, Scheerer P, Tarabykin V, Ruprecht K, Izsvak Z, Mayer J, Lehnardt S. Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors. JCI Insight. 2020;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205273</ArticleId><ArticleId IdType="pubmed">32271161</ArticleId></ArticleIdList></Reference><Reference><Citation>Manghera M, Douville RN. Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? Retrovirology. 2013;10:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3598470</ArticleId><ArticleId IdType="pubmed">23394165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavie L, Kitova M, Maldener E, Meese E, Mayer J. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2) J Virol. 2005;79:876&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538560</ArticleId><ArticleId IdType="pubmed">15613316</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodosevich K, Lebedev Y, Sverdlov ED. Large-scale determination of the methylation status of retrotransposons in different tissues using a methylation tags approach. Nucleic Acids Res. 2004;32:e31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC373429</ArticleId><ArticleId IdType="pubmed">14973327</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksakova IA, Mager DL, Reiss D. Keeping active endogenous retroviral-like elements in check: the epigenetic perspective. Cell Mol Life Sci. 2008;65:3329&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18818875</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst T, Pace M, Katzourakis A, Phillips R, Klenerman P, Frater J, Magiorkinis G. Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency. Retrovirology. 2016;13:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744380</ArticleId><ArticleId IdType="pubmed">26852322</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Montojo M, Doucet-O'Hare T, Henderson L, Nath A. Human endogenous retrovirus-K (HML-2): a comprehensive review. Crit Rev Microbiol. 2018;44:715&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6342650</ArticleId><ArticleId IdType="pubmed">30318978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon MJ, Jones SP, Lovelace MD, Guillemin GJ, Brew BJ. Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis? Neurotox Res. 2016;29:201&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26563995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, Dube D, Saha AK, Gitlin SD, Omenn GS, Kaplan MH, Markovitz DM. Regulation of the HERV-K (HML-2) transcriptome by the HIV-1 Tat protein. J Virol. 2014;88:8924&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136263</ArticleId><ArticleId IdType="pubmed">24872592</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AR, Iacoangeli A, Adey BN, Bowles H, Shatunov A, Troakes C, Garson JA, McCormick AL, Al-Chalabi A. A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex. Sci Rep. 2021;11:14283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8275748</ArticleId><ArticleId IdType="pubmed">34253796</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug L, Chatterjee N, Borges-Monroy R, Hearn S, Liao WW, Morrill K, Prazak L, Rozhkov N, Theodorou D, Hammell M, Dubnau J. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS Genet. 2017;13:e1006635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5354250</ArticleId><ArticleId IdType="pubmed">28301478</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G, Klima R, Feiguin F. TDP-43 prevents retrotransposon activation in the Drosophila motor system through regulation of Dicer-2 activity. BMC Biol. 2020;18:82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334854</ArticleId><ArticleId IdType="pubmed">32620127</ArticleId></ArticleIdList></Reference><Reference><Citation>Keegan RM, Talbot LR, Chang YH, Metzger MJ, Dubnau J. Intercellular viral spread and intracellular transposition of Drosophila gypsy. PLoS Genet. 2021;17:e1009535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096092</ArticleId><ArticleId IdType="pubmed">33886543</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Jin Y, Prazak L, Hammell M, Dubnau J. Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS One. 2012;7:e44099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3434193</ArticleId><ArticleId IdType="pubmed">22957047</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology. 2001;57:995&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman PM, Festoff BW, Giron LT, Jr, Hollenbeck LC, Garruto RM, Ruscetti FW. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N Engl J Med. 1985;313:324&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">2989688</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGowan DJ, Scelsa SN, Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2001;57:1094&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571341</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci. 2006;240:59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">16236322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Mathews T, Arunodaya GR, Siddappa NB, Ranga U, Desai A, Ravi V, Taly AB. HIV-1 clade-C-associated "ALS"-like disorder: first report from India. J Neurol Sci. 2004;224:97&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">15450778</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand KS, Wadhwa A, Garg J, Mahajan RK. Amyotrophic lateral sclerosis-like presentation in a HIV-positive patient. J Int Assoc Provid AIDS Care. 2014;13:515&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24842949</ArticleId></ArticleIdList></Reference><Reference><Citation>Satin ZA, Bayat E. ALS-Like Disorder in Three HIV-Positive Patients: Case Series. Case Rep Neurol. 2021;13:59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923715</ArticleId><ArticleId IdType="pubmed">33708095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen LN, Tyagi R, Li W, Alfahad T, Smith B, Wright M, Singer EJ, Nath A. HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology. 2016;87:1756&#x2013;1762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089528</ArticleId><ArticleId IdType="pubmed">27664983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogoch, II, Wilson MR, Chad DA, Venna N. Acute lower motor neuron syndrome and spinal cord gray matter hyperintensities in HIV infection. Neurol Neuroimmunol Neuroinflamm. 2015;2:e113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4436596</ArticleId><ArticleId IdType="pubmed">26015990</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini M, Oliveira AB, Nascimento OJ, Reis CH, Leite MA, de Souza JA, Pupe C, de Souza OG, Bastos VH, de Freitas MR, Teixeira S, Bruno C, Davidovich E, Smidt B. Amyotrophic Lateral Sclerosis: New Perpectives and Update. Neurol Int. 2015;7:5885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4591493</ArticleId><ArticleId IdType="pubmed">26487927</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfahad T, Nath A. Retroviruses and amyotrophic lateral sclerosis. Antiviral Res. 2013;99:180&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723705</ArticleId><ArticleId IdType="pubmed">23707220</ArticleId></ArticleIdList></Reference><Reference><Citation>Moodley K, Bill PLA, Bhigjee AI, Patel VB. A comparative study of motor neuron disease in HIV-infected and HIV-uninfected patients. J Neurol Sci. 2019;397:96&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">30597421</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, Dougherty A, Willey E, Stanton BR, Turner MR, Ampong MA, Sakel M, Orrell RW, Howard R, Shaw CE, Leigh PN, Al-Chalabi A. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler. 2010;11:439&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo AQ. Update on Neurological Manifestations of HTLV-1 Infection. Curr Infect Dis Rep. 2015;17:459.</Citation><ArticleIdList><ArticleId IdType="pubmed">25787112</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva MT, Leite AC, Alamy AH, Chimelli L, Andrada-Serpa MJ, Araujo AQ. ALS syndrome in HTLV-I infection. Neurology. 2005;65:1332&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">16247078</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuku K, Higuchi I, Takahashi K, Moritoyo T, Arimura K, Izumo S, Akiba S, Osame M. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol. 2000;6:544&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11175327</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja D, Cabre P, Bellance R, Vernant JC. Paraplegia associated with HTLV 1 in Martinique. Study of 271 cases including 70 with neuromuscular involvement. Bull Soc Pathol Exot. 1993;86:433&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7819796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando R, Nishikawa N, Tsujii T, Iwaki H, Yabe H, Nagai M, Nomoto M. Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms. Intern Med. 2015;54:1105&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25948358</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosa SW, A.; Mishra, S.K. Rare Case of Human T-lymphotropic Virus-1 (HTLV-1) with Amyotrophic lateral sclerosis. Neurology. 2019;92:P4.9&#x2013;003.</Citation></Reference><Reference><Citation>Ferrante P, Westarp ME, Mancuso R, Puricelli S, Westarp MP, Mini M, Caputo D, Zuffolato MR. HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis. J Neurol Sci. 1995;129(Suppl):140&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">7595608</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews WD, Al-Chalabi A, Garson JA. Lack of evidence for HTLV tax-rex DNA in motor neurone disease. J Neurol Sci. 1997;153:86&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">9455984</ArticleId></ArticleIdList></Reference><Reference><Citation>Westarp MK, HH., R&#xf6;ssler, J; Fl&#xfc;ge, RM. Human spuma retrovirus antibodies in amyotrophic lateral sclerosis. Neurology Psychiatry Brain Res. 1992;1:1&#x2013;4.</Citation></Reference><Reference><Citation>Westarp ME, Bartmann P, Rossler J, Geiger E, Westphal KP, Schreiber H, Fuchs D, Westarp MP, Kornhuber HH. Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. NeuroReport. 1993;4:819&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">8394159</ArticleId></ArticleIdList></Reference><Reference><Citation>Westarp ME, Foring B, Rasmussen H, Schraff S, Mertens T, Kornhuber HH. Retroviral synthetic peptide serum antibodies in human sporadic amyotrophic lateral sclerosis. Peptides. 1994;15:207&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">8008625</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosener M, Hahn H, Kranz M, Heeney J, Rethwilm A. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol. 1996;48:222&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8801281</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Radvanyi L, Yin B, Rycaj K, Li J, Chivukula R, Lin K, Lu Y, Shen J, Chang DZ, Li D, Johanning GL, Wang-Johanning F. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth. Clin Cancer Res. 2017;23:5892&#x2013;5911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5777511</ArticleId><ArticleId IdType="pubmed">28679769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene. 2003;22:1528&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">12629516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Rycaj K, Geng S, Li M, Plummer JB, Yin B, Liu H, Xu X, Zhang Y, Yan Y, Glynn SA, Dorsey TH, Ambs S, Johanning GL, Gu L, Wang-Johanning F. Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer. Genes Cancer. 2011;2:914&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3352153</ArticleId><ArticleId IdType="pubmed">22593804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, Plummer JB, Garza JG, Ambs S, Johanning GL. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Int J Cancer. 2014;134:587&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4191919</ArticleId><ArticleId IdType="pubmed">23873154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Krishnamurthy J, Wei Y, Li M, Hunt K, Johanning GL, Cooper LJ, Wang-Johanning F. Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras. Oncoimmunology. 2015;4:e1047582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589998</ArticleId><ArticleId IdType="pubmed">26451325</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum LL, Patton G, Grigg AR, Frater AJ, Cain D, Erlwein O, Hill CL, Clarke JR, McClure MO. Differential susceptibility of retroviruses to nucleoside analogues. Antivir Chem Chemother. 2001;12:91&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11527046</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras-Galindo R, Dube D, Fujinaga K, Kaplan MH, Markovitz DM. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors. J Virol. 2017;91:e01309&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5686744</ArticleId><ArticleId IdType="pubmed">28931682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi R, Li W, Parades D, Bianchet MA, Nath A. Inhibition of human endogenous retrovirus-K by antiretroviral drugs. Retrovirology. 2017;14:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5361811</ArticleId><ArticleId IdType="pubmed">28330477</ArticleId></ArticleIdList></Reference><Reference><Citation>Towler EM, Gulnik SV, Bhat TN, Xie D, Gustschina E, Sumpter TR, Robertson N, Jones C, Sauter M, Mueller-Lantzsch N, Debouck C, Erickson JW. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease? Biochemistry. 1998;37:17137&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">9860826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhelj R, Rizzo CJ, Chang CH, Jadhav PK, Towler EM, Korant BD. Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays. J Biol Chem. 2001;276:16674&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11278433</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi RLW, Parades D, Bianchet M, Nath A. Inhibition of human endogenous retrovirus-K replication by antiretroviral drugs. Retrovirology. 2017;14:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5361811</ArticleId><ArticleId IdType="pubmed">28330477</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwogu JN, Ma Q, Babalola CP, Adedeji WA, Morse GD, Taiwo B. Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals. AIDS Res Treat. 2016;2016:2587094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5061948</ArticleId><ArticleId IdType="pubmed">27777797</ArticleId></ArticleIdList></Reference><Reference><Citation>Asahchop EL, Meziane O, Mamik MK, Chan WF, Branton WG, Resch L, Gill MJ, Haddad E, Guimond JV, Wainberg MA, Baker GB, Cohen EA, Power C. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain. Retrovirology. 2017;14:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5644262</ArticleId><ArticleId IdType="pubmed">29037245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara M, Bumpus NN, Ma Q, Ellis RJ, Soontornniyomkij V, Fields JA, Bharti A, Achim CL, Moore DJ, Letendre SL. Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS. 2020;34:1907&#x2013;1914.</Citation><ArticleIdList><ArticleId IdType="pubmed">32694413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanman T, Letendre S, Ma Q, Bang A, Ellis R. CNS Neurotoxicity of Antiretrovirals. J Neuroimmune Pharmacol. 2021;16:130&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282963</ArticleId><ArticleId IdType="pubmed">31823251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dube D, Contreras-Galindo R, He S, King SR, Gonzalez-Hernandez MJ, Gitlin SD, Kaplan MH, Markovitz DM. Genomic Flexibility of Human Endogenous Retrovirus Type K. J Virol. 2014 doi: 10.1128/JVI.01147-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01147-14</ArticleId><ArticleId IdType="pmc">PMC4136327</ArticleId><ArticleId IdType="pubmed">24920813</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Montojo M, Fathi S, Norato G, Smith BR, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Santamaria U, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A, Gold J, Nath A. Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy. J Neurol Sci. 2021;423:117358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009857</ArticleId><ArticleId IdType="pubmed">33653604</ArticleId></ArticleIdList></Reference><Reference><Citation>Scelsa SN, MacGowan DJ, Mitsumoto H, Imperato T, LeValley AJ, Liu MH, DelBene M, Kim MY. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS. Neurology. 2005;64:1298&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">15824372</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen LTR, Li W, Alfahad T, Smith B, Singer EJ, Nath A. HIV-associated Motor Neuron Disease: HERV-K activation and response to Anti-Retroviral Therapy. Neurology. 2016;87:1756&#x2013;1762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089528</ArticleId><ArticleId IdType="pubmed">27664983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A. Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:595&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">31284774</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A, Johnson TP. Mechanisms of viral persistence in the brain and therapeutic approaches. FEBS J. 2021 doi: 10.1111/febs.15871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15871</ArticleId><ArticleId IdType="pubmed">33844441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazazian HH. Mobile DNA transposition in somatic cells. BMC Biol. 2011;9:62&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182954</ArticleId><ArticleId IdType="pubmed">21958341</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>